Cargando…
Fumarate hydratase deficiency induces chronic myeloid leukemia progression
BACKGROUND: Although tyrosine kinase inhibitors (TKIs) have profoundly improved the prognosis of chronic myeloid leukemia (CML), the mechanism of the progression to blast phase (BP) is currently unclear. Our previous study indicated that CML-BP cells utilize glycolysis to proliferate and that the fu...
Autores principales: | Li, Shan, Qiao, Chun, Yang, Lijia, Hong, Ming, Fang, Yu, Jin, Hui, Li, Jianyong, Qian, Sixuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797861/ https://www.ncbi.nlm.nih.gov/pubmed/35116792 http://dx.doi.org/10.21037/tcr.2019.03.23 |
Ejemplares similares
-
Structural basis of fumarate hydratase deficiency
por: Picaud, Sarah, et al.
Publicado: (2011) -
Inhibition of Mitochondrial Aconitase by Succination in Fumarate Hydratase Deficiency
por: Ternette, Nicola, et al.
Publicado: (2013) -
Uterine leiomyoma with fumarate hydratase deficiency: A case report
por: Huang, Yan, et al.
Publicado: (2021) -
The Waldo of fibroids under the microscope: fumarate hydratase–deficient leiomyomata
por: Punjabi, Lavisha S., et al.
Publicado: (2022) -
HIF and fumarate hydratase in renal cancer
por: Sudarshan, S, et al.
Publicado: (2007)